nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Glyburide—type 2 diabetes mellitus	0.0927	0.128	CbGbCtD
Idarubicin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0623	0.0859	CbGbCtD
Idarubicin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.057	0.0786	CbGbCtD
Idarubicin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.053	0.0731	CbGbCtD
Idarubicin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.045	0.0621	CbGbCtD
Idarubicin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.045	0.0621	CbGbCtD
Idarubicin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0416	0.0573	CbGbCtD
Idarubicin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0412	0.0568	CbGbCtD
Idarubicin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0401	0.0554	CbGbCtD
Idarubicin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.038	0.0524	CbGbCtD
Idarubicin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0367	0.0506	CbGbCtD
Idarubicin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0341	0.0471	CbGbCtD
Idarubicin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0327	0.0451	CbGbCtD
Idarubicin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0312	0.0431	CbGbCtD
Idarubicin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0299	0.0413	CbGbCtD
Idarubicin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.023	0.0318	CbGbCtD
Idarubicin—CYP2C9—Losartan—type 2 diabetes mellitus	0.0211	0.0291	CbGbCtD
Idarubicin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.0025	0.724	CbGdCrCtD
Idarubicin—Doxorubicin—NOS1—type 2 diabetes mellitus	0.00184	0.288	CrCbGaD
Idarubicin—Doxorubicin—NOS3—type 2 diabetes mellitus	0.001	0.156	CrCbGaD
Idarubicin—Doxorubicin—NOS2—type 2 diabetes mellitus	0.000966	0.151	CrCbGaD
Idarubicin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.000951	0.276	CbGdCrCtD
Idarubicin—Daunorubicin—ABCC2—type 2 diabetes mellitus	0.000789	0.123	CrCbGaD
Idarubicin—Doxorubicin—ABCC2—type 2 diabetes mellitus	0.000641	0.1	CrCbGaD
Idarubicin—Daunorubicin—CYP1A2—type 2 diabetes mellitus	0.000527	0.0824	CrCbGaD
Idarubicin—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000401	0.00199	CcSEcCtD
Idarubicin—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000399	0.00198	CcSEcCtD
Idarubicin—Infection—Bromocriptine—type 2 diabetes mellitus	0.000398	0.00197	CcSEcCtD
Idarubicin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000394	0.00196	CcSEcCtD
Idarubicin—Shock—Bromocriptine—type 2 diabetes mellitus	0.000394	0.00195	CcSEcCtD
Idarubicin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000393	0.00195	CcSEcCtD
Idarubicin—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000389	0.00193	CcSEcCtD
Idarubicin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000389	0.00193	CcSEcCtD
Idarubicin—Convulsion—Glyburide—type 2 diabetes mellitus	0.000388	0.00193	CcSEcCtD
Idarubicin—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000386	0.00191	CcSEcCtD
Idarubicin—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000386	0.00191	CcSEcCtD
Idarubicin—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000385	0.00191	CcSEcCtD
Idarubicin—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000384	0.0019	CcSEcCtD
Idarubicin—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000382	0.00189	CcSEcCtD
Idarubicin—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000379	0.00188	CcSEcCtD
Idarubicin—Urticaria—Glipizide—type 2 diabetes mellitus	0.000378	0.00187	CcSEcCtD
Idarubicin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000376	0.00186	CcSEcCtD
Idarubicin—Alopecia—Valsartan—type 2 diabetes mellitus	0.000376	0.00186	CcSEcCtD
Idarubicin—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000372	0.00185	CcSEcCtD
Idarubicin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000372	0.00184	CcSEcCtD
Idarubicin—Alopecia—Orlistat—type 2 diabetes mellitus	0.000371	0.00184	CcSEcCtD
Idarubicin—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00037	0.00183	CcSEcCtD
Idarubicin—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000366	0.00181	CcSEcCtD
Idarubicin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000365	0.00181	CcSEcCtD
Idarubicin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000363	0.0018	CcSEcCtD
Idarubicin—Rash—Repaglinide—type 2 diabetes mellitus	0.000362	0.0018	CcSEcCtD
Idarubicin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000362	0.0018	CcSEcCtD
Idarubicin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000362	0.0018	CcSEcCtD
Idarubicin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000362	0.00179	CcSEcCtD
Idarubicin—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000361	0.00179	CcSEcCtD
Idarubicin—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.00036	0.00179	CcSEcCtD
Idarubicin—Headache—Repaglinide—type 2 diabetes mellitus	0.00036	0.00179	CcSEcCtD
Idarubicin—Shock—Glyburide—type 2 diabetes mellitus	0.00036	0.00179	CcSEcCtD
Idarubicin—Flushing—Metformin—type 2 diabetes mellitus	0.000359	0.00178	CcSEcCtD
Idarubicin—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000358	0.00178	CcSEcCtD
Idarubicin—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000358	0.00178	CcSEcCtD
Idarubicin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000353	0.00175	CcSEcCtD
Idarubicin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000351	0.00174	CcSEcCtD
Idarubicin—Angiopathy—Metformin—type 2 diabetes mellitus	0.000351	0.00174	CcSEcCtD
Idarubicin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000351	0.00174	CcSEcCtD
Idarubicin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00035	0.00174	CcSEcCtD
Idarubicin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00035	0.00173	CcSEcCtD
Idarubicin—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.00035	0.00173	CcSEcCtD
Idarubicin—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00035	0.00173	CcSEcCtD
Idarubicin—Daunorubicin—CYP3A4—type 2 diabetes mellitus	0.000349	0.0546	CrCbGaD
Idarubicin—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000349	0.00173	CcSEcCtD
Idarubicin—Anorexia—Glyburide—type 2 diabetes mellitus	0.000349	0.00173	CcSEcCtD
Idarubicin—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000348	0.00173	CcSEcCtD
Idarubicin—Chills—Metformin—type 2 diabetes mellitus	0.000347	0.00172	CcSEcCtD
Idarubicin—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000344	0.00171	CcSEcCtD
Idarubicin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000343	0.0017	CcSEcCtD
Idarubicin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000342	0.0017	CcSEcCtD
Idarubicin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000342	0.0017	CcSEcCtD
Idarubicin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000341	0.00169	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00034	0.00169	CcSEcCtD
Idarubicin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00034	0.00169	CcSEcCtD
Idarubicin—Flushing—Irbesartan—type 2 diabetes mellitus	0.000339	0.00168	CcSEcCtD
Idarubicin—Malnutrition—Metformin—type 2 diabetes mellitus	0.000337	0.00167	CcSEcCtD
Idarubicin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000336	0.00166	CcSEcCtD
Idarubicin—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000331	0.00164	CcSEcCtD
Idarubicin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00033	0.00164	CcSEcCtD
Idarubicin—Chills—Irbesartan—type 2 diabetes mellitus	0.000328	0.00163	CcSEcCtD
Idarubicin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000327	0.00162	CcSEcCtD
Idarubicin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000327	0.00162	CcSEcCtD
Idarubicin—Infection—Gliclazide—type 2 diabetes mellitus	0.000326	0.00162	CcSEcCtD
Idarubicin—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000326	0.00162	CcSEcCtD
Idarubicin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00162	CcSEcCtD
Idarubicin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000325	0.00161	CcSEcCtD
Idarubicin—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000324	0.00161	CcSEcCtD
Idarubicin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000323	0.0016	CcSEcCtD
Idarubicin—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000322	0.0016	CcSEcCtD
Idarubicin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000322	0.0016	CcSEcCtD
Idarubicin—Stomatitis—Ramipril—type 2 diabetes mellitus	0.00032	0.00159	CcSEcCtD
Idarubicin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000319	0.00158	CcSEcCtD
Idarubicin—Flushing—Losartan—type 2 diabetes mellitus	0.000319	0.00158	CcSEcCtD
Idarubicin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000318	0.00158	CcSEcCtD
Idarubicin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00158	CcSEcCtD
Idarubicin—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000318	0.00158	CcSEcCtD
Idarubicin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000317	0.00157	CcSEcCtD
Idarubicin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000316	0.00157	CcSEcCtD
Idarubicin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000316	0.00157	CcSEcCtD
Idarubicin—Chest pain—Valsartan—type 2 diabetes mellitus	0.000315	0.00156	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000313	0.00155	CcSEcCtD
Idarubicin—Angiopathy—Losartan—type 2 diabetes mellitus	0.000312	0.00155	CcSEcCtD
Idarubicin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000312	0.00155	CcSEcCtD
Idarubicin—Chest pain—Orlistat—type 2 diabetes mellitus	0.000311	0.00154	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000309	0.00153	CcSEcCtD
Idarubicin—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000307	0.00152	CcSEcCtD
Idarubicin—Alopecia—Losartan—type 2 diabetes mellitus	0.000304	0.00151	CcSEcCtD
Idarubicin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000304	0.00151	CcSEcCtD
Idarubicin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000303	0.0015	CcSEcCtD
Idarubicin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000302	0.0015	CcSEcCtD
Idarubicin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000302	0.0015	CcSEcCtD
Idarubicin—Infection—Valsartan—type 2 diabetes mellitus	0.0003	0.00149	CcSEcCtD
Idarubicin—Rash—Glipizide—type 2 diabetes mellitus	0.0003	0.00149	CcSEcCtD
Idarubicin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0003	0.00149	CcSEcCtD
Idarubicin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000299	0.00148	CcSEcCtD
Idarubicin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000298	0.00148	CcSEcCtD
Idarubicin—Headache—Glipizide—type 2 diabetes mellitus	0.000298	0.00148	CcSEcCtD
Idarubicin—Shock—Valsartan—type 2 diabetes mellitus	0.000297	0.00147	CcSEcCtD
Idarubicin—Infection—Orlistat—type 2 diabetes mellitus	0.000296	0.00147	CcSEcCtD
Idarubicin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000296	0.00147	CcSEcCtD
Idarubicin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000294	0.00146	CcSEcCtD
Idarubicin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000293	0.00145	CcSEcCtD
Idarubicin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000291	0.00144	CcSEcCtD
Idarubicin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00029	0.00144	CcSEcCtD
Idarubicin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000289	0.00143	CcSEcCtD
Idarubicin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000288	0.00143	CcSEcCtD
Idarubicin—Chest pain—Metformin—type 2 diabetes mellitus	0.000287	0.00142	CcSEcCtD
Idarubicin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000285	0.00142	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000285	0.00141	CcSEcCtD
Idarubicin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000285	0.00141	CcSEcCtD
Idarubicin—Doxorubicin—CYP3A4—type 2 diabetes mellitus	0.000283	0.0443	CrCbGaD
Idarubicin—Nausea—Glipizide—type 2 diabetes mellitus	0.000282	0.0014	CcSEcCtD
Idarubicin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000282	0.0014	CcSEcCtD
Idarubicin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000281	0.0014	CcSEcCtD
Idarubicin—Rash—Glimepiride—type 2 diabetes mellitus	0.00028	0.00139	CcSEcCtD
Idarubicin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00028	0.00139	CcSEcCtD
Idarubicin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00138	CcSEcCtD
Idarubicin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000279	0.00138	CcSEcCtD
Idarubicin—Headache—Glimepiride—type 2 diabetes mellitus	0.000278	0.00138	CcSEcCtD
Idarubicin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000277	0.00137	CcSEcCtD
Idarubicin—Anaemia—Losartan—type 2 diabetes mellitus	0.000277	0.00137	CcSEcCtD
Idarubicin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000274	0.00136	CcSEcCtD
Idarubicin—Flushing—Ramipril—type 2 diabetes mellitus	0.000273	0.00136	CcSEcCtD
Idarubicin—Infection—Metformin—type 2 diabetes mellitus	0.000273	0.00135	CcSEcCtD
Idarubicin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000271	0.00134	CcSEcCtD
Idarubicin—Shock—Metformin—type 2 diabetes mellitus	0.00027	0.00134	CcSEcCtD
Idarubicin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00027	0.00134	CcSEcCtD
Idarubicin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000269	0.00134	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000269	0.00133	CcSEcCtD
Idarubicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000269	0.00133	CcSEcCtD
Idarubicin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000268	0.00133	CcSEcCtD
Idarubicin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000267	0.00132	CcSEcCtD
Idarubicin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000266	0.00132	CcSEcCtD
Idarubicin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000264	0.00131	CcSEcCtD
Idarubicin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000263	0.00131	CcSEcCtD
Idarubicin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000263	0.0013	CcSEcCtD
Idarubicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000262	0.0013	CcSEcCtD
Idarubicin—Anorexia—Metformin—type 2 diabetes mellitus	0.000262	0.0013	CcSEcCtD
Idarubicin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000261	0.00129	CcSEcCtD
Idarubicin—Alopecia—Ramipril—type 2 diabetes mellitus	0.00026	0.00129	CcSEcCtD
Idarubicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00026	0.00129	CcSEcCtD
Idarubicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00026	0.00129	CcSEcCtD
Idarubicin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000259	0.00129	CcSEcCtD
Idarubicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000259	0.00129	CcSEcCtD
Idarubicin—Infection—Irbesartan—type 2 diabetes mellitus	0.000258	0.00128	CcSEcCtD
Idarubicin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000257	0.00127	CcSEcCtD
Idarubicin—Shock—Irbesartan—type 2 diabetes mellitus	0.000255	0.00127	CcSEcCtD
Idarubicin—Chest pain—Losartan—type 2 diabetes mellitus	0.000255	0.00126	CcSEcCtD
Idarubicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000255	0.00126	CcSEcCtD
Idarubicin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000254	0.00126	CcSEcCtD
Idarubicin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00125	CcSEcCtD
Idarubicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000252	0.00125	CcSEcCtD
Idarubicin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000252	0.00125	CcSEcCtD
Idarubicin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000251	0.00124	CcSEcCtD
Idarubicin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00025	0.00124	CcSEcCtD
Idarubicin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000247	0.00123	CcSEcCtD
Idarubicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000247	0.00122	CcSEcCtD
Idarubicin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000244	0.00121	CcSEcCtD
Idarubicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000244	0.00121	CcSEcCtD
Idarubicin—Infection—Losartan—type 2 diabetes mellitus	0.000243	0.0012	CcSEcCtD
Idarubicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000242	0.0012	CcSEcCtD
Idarubicin—Shock—Losartan—type 2 diabetes mellitus	0.00024	0.00119	CcSEcCtD
Idarubicin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00024	0.00119	CcSEcCtD
Idarubicin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000239	0.00119	CcSEcCtD
Idarubicin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000239	0.00119	CcSEcCtD
Idarubicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000239	0.00118	CcSEcCtD
Idarubicin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00118	CcSEcCtD
Idarubicin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000237	0.00118	CcSEcCtD
Idarubicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000236	0.00117	CcSEcCtD
Idarubicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000236	0.00117	CcSEcCtD
Idarubicin—Anorexia—Losartan—type 2 diabetes mellitus	0.000233	0.00115	CcSEcCtD
Idarubicin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000233	0.00115	CcSEcCtD
Idarubicin—Rash—Glyburide—type 2 diabetes mellitus	0.000231	0.00114	CcSEcCtD
Idarubicin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000231	0.00114	CcSEcCtD
Idarubicin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.00023	0.00114	CcSEcCtD
Idarubicin—Headache—Glyburide—type 2 diabetes mellitus	0.000229	0.00114	CcSEcCtD
Idarubicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000226	0.00112	CcSEcCtD
Idarubicin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000225	0.00112	CcSEcCtD
Idarubicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000225	0.00112	CcSEcCtD
Idarubicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000222	0.0011	CcSEcCtD
Idarubicin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000222	0.0011	CcSEcCtD
Idarubicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00022	0.00109	CcSEcCtD
Idarubicin—Urticaria—Metformin—type 2 diabetes mellitus	0.000218	0.00108	CcSEcCtD
Idarubicin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000218	0.00108	CcSEcCtD
Idarubicin—Nausea—Glyburide—type 2 diabetes mellitus	0.000217	0.00108	CcSEcCtD
Idarubicin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000217	0.00108	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000217	0.00108	CcSEcCtD
Idarubicin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000212	0.00105	CcSEcCtD
Idarubicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000212	0.00105	CcSEcCtD
Idarubicin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000209	0.00104	CcSEcCtD
Idarubicin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000209	0.00104	CcSEcCtD
Idarubicin—Rash—Gliclazide—type 2 diabetes mellitus	0.000207	0.00103	CcSEcCtD
Idarubicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000207	0.00103	CcSEcCtD
Idarubicin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000207	0.00102	CcSEcCtD
Idarubicin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000206	0.00102	CcSEcCtD
Idarubicin—Shock—Ramipril—type 2 diabetes mellitus	0.000206	0.00102	CcSEcCtD
Idarubicin—Headache—Gliclazide—type 2 diabetes mellitus	0.000206	0.00102	CcSEcCtD
Idarubicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000205	0.00102	CcSEcCtD
Idarubicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000205	0.00102	CcSEcCtD
Idarubicin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000205	0.00102	CcSEcCtD
Idarubicin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000204	0.00101	CcSEcCtD
Idarubicin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000203	0.00101	CcSEcCtD
Idarubicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.0002	0.00099	CcSEcCtD
Idarubicin—Anorexia—Ramipril—type 2 diabetes mellitus	0.0002	0.00099	CcSEcCtD
Idarubicin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000195	0.000968	CcSEcCtD
Idarubicin—Urticaria—Losartan—type 2 diabetes mellitus	0.000194	0.000962	CcSEcCtD
Idarubicin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000193	0.000957	CcSEcCtD
Idarubicin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000193	0.000957	CcSEcCtD
Idarubicin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000192	0.000952	CcSEcCtD
Idarubicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000191	0.000948	CcSEcCtD
Idarubicin—Rash—Valsartan—type 2 diabetes mellitus	0.00019	0.000944	CcSEcCtD
Idarubicin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00019	0.000943	CcSEcCtD
Idarubicin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00019	0.000941	CcSEcCtD
Idarubicin—Headache—Valsartan—type 2 diabetes mellitus	0.000189	0.000938	CcSEcCtD
Idarubicin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000188	0.000933	CcSEcCtD
Idarubicin—Rash—Orlistat—type 2 diabetes mellitus	0.000188	0.000933	CcSEcCtD
Idarubicin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000188	0.000932	CcSEcCtD
Idarubicin—Headache—Orlistat—type 2 diabetes mellitus	0.000187	0.000927	CcSEcCtD
Idarubicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000182	0.000903	CcSEcCtD
Idarubicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00018	0.000892	CcSEcCtD
Idarubicin—Nausea—Valsartan—type 2 diabetes mellitus	0.000179	0.00089	CcSEcCtD
Idarubicin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000178	0.000881	CcSEcCtD
Idarubicin—Nausea—Orlistat—type 2 diabetes mellitus	0.000177	0.000879	CcSEcCtD
Idarubicin—Vomiting—Metformin—type 2 diabetes mellitus	0.000175	0.000867	CcSEcCtD
Idarubicin—Rash—Metformin—type 2 diabetes mellitus	0.000173	0.00086	CcSEcCtD
Idarubicin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000173	0.000859	CcSEcCtD
Idarubicin—Headache—Metformin—type 2 diabetes mellitus	0.000172	0.000854	CcSEcCtD
Idarubicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000171	0.000849	CcSEcCtD
Idarubicin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000167	0.000829	CcSEcCtD
Idarubicin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000166	0.000825	CcSEcCtD
Idarubicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000166	0.000821	CcSEcCtD
Idarubicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000166	0.000821	CcSEcCtD
Idarubicin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000165	0.000818	CcSEcCtD
Idarubicin—Rash—Irbesartan—type 2 diabetes mellitus	0.000164	0.000811	CcSEcCtD
Idarubicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000163	0.000811	CcSEcCtD
Idarubicin—Nausea—Metformin—type 2 diabetes mellitus	0.000163	0.00081	CcSEcCtD
Idarubicin—Headache—Irbesartan—type 2 diabetes mellitus	0.000163	0.000806	CcSEcCtD
Idarubicin—Vomiting—Losartan—type 2 diabetes mellitus	0.000155	0.00077	CcSEcCtD
Idarubicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000154	0.000765	CcSEcCtD
Idarubicin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000154	0.000764	CcSEcCtD
Idarubicin—Rash—Losartan—type 2 diabetes mellitus	0.000154	0.000764	CcSEcCtD
Idarubicin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000154	0.000763	CcSEcCtD
Idarubicin—Headache—Losartan—type 2 diabetes mellitus	0.000153	0.000759	CcSEcCtD
Idarubicin—Nausea—Losartan—type 2 diabetes mellitus	0.000145	0.000719	CcSEcCtD
Idarubicin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000143	0.000711	CcSEcCtD
Idarubicin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000133	0.00066	CcSEcCtD
Idarubicin—Rash—Ramipril—type 2 diabetes mellitus	0.000132	0.000655	CcSEcCtD
Idarubicin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000132	0.000654	CcSEcCtD
Idarubicin—Headache—Ramipril—type 2 diabetes mellitus	0.000131	0.000651	CcSEcCtD
Idarubicin—Nausea—Ramipril—type 2 diabetes mellitus	0.000124	0.000617	CcSEcCtD
Idarubicin—ABCC1—Metabolism—GCK—type 2 diabetes mellitus	3.08e-05	0.000483	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LIPC—type 2 diabetes mellitus	3.08e-05	0.000483	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HBA1—type 2 diabetes mellitus	3.08e-05	0.000483	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.08e-05	0.000482	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.06e-05	0.00048	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.06e-05	0.000479	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	3.03e-05	0.000474	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.01e-05	0.000471	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	3e-05	0.00047	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC2A1—type 2 diabetes mellitus	2.98e-05	0.000468	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CETP—type 2 diabetes mellitus	2.97e-05	0.000466	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	2.97e-05	0.000465	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS1—type 2 diabetes mellitus	2.94e-05	0.000461	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TCF7L2—type 2 diabetes mellitus	2.91e-05	0.000456	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SLC2A4—type 2 diabetes mellitus	2.86e-05	0.000448	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	2.79e-05	0.000438	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	2.79e-05	0.000438	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.77e-05	0.000434	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	2.77e-05	0.000434	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	2.77e-05	0.000434	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PSMD6—type 2 diabetes mellitus	2.76e-05	0.000433	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SREBF1—type 2 diabetes mellitus	2.76e-05	0.000433	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SNAP25—type 2 diabetes mellitus	2.76e-05	0.000433	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.76e-05	0.000432	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CTGF—type 2 diabetes mellitus	2.71e-05	0.000425	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.71e-05	0.000424	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	2.7e-05	0.000423	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	2.7e-05	0.000423	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	2.7e-05	0.000423	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.7e-05	0.000423	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	2.7e-05	0.000423	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HMGCR—type 2 diabetes mellitus	2.69e-05	0.000421	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.68e-05	0.00042	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	2.68e-05	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.68e-05	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	2.68e-05	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	2.68e-05	0.000419	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	2.68e-05	0.000419	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.65e-05	0.000415	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.64e-05	0.000413	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.63e-05	0.000412	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	2.61e-05	0.00041	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	2.59e-05	0.000406	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.53e-05	0.000396	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.5e-05	0.000392	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.5e-05	0.000392	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.49e-05	0.000391	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFBR2—type 2 diabetes mellitus	2.49e-05	0.00039	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	2.47e-05	0.000387	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	2.47e-05	0.000387	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	2.45e-05	0.000383	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	2.45e-05	0.000383	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.44e-05	0.000382	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.43e-05	0.00038	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CDKN2B—type 2 diabetes mellitus	2.41e-05	0.000378	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	2.41e-05	0.000377	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GCG—type 2 diabetes mellitus	2.4e-05	0.000375	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.4e-05	0.000375	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	2.38e-05	0.000374	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APOB—type 2 diabetes mellitus	2.35e-05	0.000368	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	2.29e-05	0.00036	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	2.29e-05	0.00036	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	2.29e-05	0.00036	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.27e-05	0.000356	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.27e-05	0.000356	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.27e-05	0.000356	CbGpPWpGaD
Idarubicin—ABCC1—Disease—LPL—type 2 diabetes mellitus	2.25e-05	0.000352	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	2.2e-05	0.000345	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	2.2e-05	0.000345	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ADCY5—type 2 diabetes mellitus	2.2e-05	0.000344	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.18e-05	0.000342	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.18e-05	0.000342	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	2.12e-05	0.000332	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	2.12e-05	0.000332	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PPP2CA—type 2 diabetes mellitus	2.11e-05	0.00033	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2.1e-05	0.000329	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2.1e-05	0.000329	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	2.08e-05	0.000326	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CCR5—type 2 diabetes mellitus	2.07e-05	0.000324	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.07e-05	0.000324	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GNB3—type 2 diabetes mellitus	2.07e-05	0.000324	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	2.06e-05	0.000323	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.06e-05	0.000323	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—HMOX1—type 2 diabetes mellitus	2.06e-05	0.000322	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	2.05e-05	0.00032	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	2.05e-05	0.00032	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	2.05e-05	0.00032	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CAT—type 2 diabetes mellitus	2.03e-05	0.000318	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	2.03e-05	0.000318	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	2.03e-05	0.000318	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	2.03e-05	0.000318	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	2.02e-05	0.000317	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	1.97e-05	0.000309	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.97e-05	0.000308	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	1.93e-05	0.000302	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IRS2—type 2 diabetes mellitus	1.92e-05	0.000301	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	1.92e-05	0.000301	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	1.92e-05	0.0003	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.91e-05	0.000299	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CALM1—type 2 diabetes mellitus	1.89e-05	0.000296	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APOE—type 2 diabetes mellitus	1.88e-05	0.000295	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	1.88e-05	0.000295	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.88e-05	0.000294	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APOA1—type 2 diabetes mellitus	1.86e-05	0.000292	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	1.84e-05	0.000288	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	1.83e-05	0.000287	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.83e-05	0.000287	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	1.8e-05	0.000282	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	1.79e-05	0.00028	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	1.79e-05	0.00028	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.78e-05	0.000279	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.76e-05	0.000276	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS2—type 2 diabetes mellitus	1.75e-05	0.000275	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	1.74e-05	0.000272	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	1.74e-05	0.000272	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	1.74e-05	0.000272	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	1.74e-05	0.000272	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	1.72e-05	0.00027	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	1.72e-05	0.00027	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	1.72e-05	0.00027	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	1.72e-05	0.00027	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	1.69e-05	0.000265	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IRS1—type 2 diabetes mellitus	1.68e-05	0.000263	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	1.67e-05	0.000261	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	1.66e-05	0.00026	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.66e-05	0.00026	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	1.65e-05	0.000259	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	1.61e-05	0.000252	CbGpPWpGaD
Idarubicin—ABCC1—Disease—INS—type 2 diabetes mellitus	1.61e-05	0.000252	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.61e-05	0.000252	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	1.58e-05	0.000248	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	1.58e-05	0.000247	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.57e-05	0.000246	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	1.56e-05	0.000244	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.56e-05	0.000244	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT2—type 2 diabetes mellitus	1.55e-05	0.000244	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	1.55e-05	0.000243	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.54e-05	0.000241	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	1.48e-05	0.000231	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	1.45e-05	0.000227	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.43e-05	0.000225	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	1.42e-05	0.000222	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	1.42e-05	0.000222	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOS3—type 2 diabetes mellitus	1.41e-05	0.000221	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	1.41e-05	0.000221	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.41e-05	0.00022	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.41e-05	0.00022	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	1.39e-05	0.000218	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	1.38e-05	0.000216	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	1.38e-05	0.000216	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	1.38e-05	0.000216	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.38e-05	0.000216	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.37e-05	0.000215	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.36e-05	0.000213	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	1.35e-05	0.000211	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—INS—type 2 diabetes mellitus	1.35e-05	0.000211	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.34e-05	0.000209	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	1.33e-05	0.000209	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.32e-05	0.000207	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	1.29e-05	0.000202	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	1.24e-05	0.000194	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	1.24e-05	0.000194	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	1.24e-05	0.000194	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	1.23e-05	0.000193	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.23e-05	0.000193	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.23e-05	0.000192	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.23e-05	0.000192	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.23e-05	0.000192	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	1.22e-05	0.000191	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.21e-05	0.000189	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	1.21e-05	0.000189	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.19e-05	0.000187	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	1.18e-05	0.000185	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000185	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	1.18e-05	0.000185	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.18e-05	0.000185	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.17e-05	0.000183	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.13e-05	0.000178	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.12e-05	0.000176	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.12e-05	0.000176	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.12e-05	0.000176	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.11e-05	0.000174	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.11e-05	0.000174	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.09e-05	0.000171	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.08e-05	0.00017	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	1.08e-05	0.000169	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.08e-05	0.000169	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.07e-05	0.000168	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.07e-05	0.000168	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.07e-05	0.000167	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.07e-05	0.000167	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SRC—type 2 diabetes mellitus	1.04e-05	0.000163	CbGpPWpGaD
Idarubicin—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	9.32e-06	0.000146	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	9.26e-06	0.000145	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.26e-06	0.000145	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	9.22e-06	0.000144	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	9.18e-06	0.000144	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.18e-06	0.000144	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—type 2 diabetes mellitus	9.14e-06	0.000143	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	9.14e-06	0.000143	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	9.09e-06	0.000142	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	9.02e-06	0.000141	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	8.83e-06	0.000138	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	8.75e-06	0.000137	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	8.59e-06	0.000135	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	8.51e-06	0.000133	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	8.43e-06	0.000132	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	8.36e-06	0.000131	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	8.25e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	8.23e-06	0.000129	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	8.18e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	8.15e-06	0.000128	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	8.01e-06	0.000126	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	7.94e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	7.91e-06	0.000124	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	7.84e-06	0.000123	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	7.59e-06	0.000119	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	7.53e-06	0.000118	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	7.45e-06	0.000117	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	7.38e-06	0.000116	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	7.21e-06	0.000113	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	7.15e-06	0.000112	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	7.09e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	7.07e-06	0.000111	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	7.03e-06	0.00011	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IL6—type 2 diabetes mellitus	7.03e-06	0.00011	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	7.01e-06	0.00011	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.99e-06	0.000109	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.93e-06	0.000109	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—type 2 diabetes mellitus	6.48e-06	0.000102	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	6.16e-06	9.64e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	6.1e-06	9.56e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	6.04e-06	9.46e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.98e-06	9.38e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.53e-06	8.67e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.49e-06	8.6e-05	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	5.43e-06	8.51e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	5.29e-06	8.29e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	5.29e-06	8.29e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	5.25e-06	8.22e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	5.25e-06	8.22e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.84e-06	7.59e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.8e-06	7.52e-05	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.43e-06	3.81e-05	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.41e-06	3.78e-05	CbGpPWpGaD
